FDA Leader Accused of Sexual Harassment; RFK Jr.’s Toilet Comment; GLP-1s and ScurvyFDA Leader Accused of Sexual Harassment; RFK Jr.’s Toilet Comment; GLP-1s and Scurvy
(MedPage Today) — Note that some links may require registration or subscription. FDA vaccine chief Vinay Prasad, MD, MPH, who made the controversial decision to refuse to review Moderna’s mRNA flu vaccine, has been accused of sexual harassment… (MedPage Today) — Note that some links may require registration or subscription. FDA vaccine chief Vinay Read More
STAT+: Trump administration is urged to use a federal law to authorize generic versions of GLP-1 drugsSTAT+: Trump administration is urged to use a federal law to authorize generic versions of GLP-1 drugs
Public Citizen petitioned the Trump administration to use a federal law to authorize generic competitors for GLP-1 drugs for treating obesity and diabetes, arguing that prices are “unjustifiably high” for too many Americans. In arguing its case, the consumer advocacy group maintained that federal and state spending on the drugs — which are sold by Read More
Potentially Blinding Eye Condition Tied to Ozempic AgainPotentially Blinding Eye Condition Tied to Ozempic Again
(MedPage Today) — Risk for a rare, potentially blinding eye condition was low, but it was significantly higher in diabetes patients who started semaglutide (Ozempic) versus SGLT2 inhibitors, an observational study of U.S. veterans showed. Among… (MedPage Today) — Risk for a rare, potentially blinding eye condition was low, but it was significantly higher Read More
Genetic risk may rival obesity as a key driver of endometrial cancerGenetic risk may rival obesity as a key driver of endometrial cancer
A major new study has found genetics play a powerful and independent role in endometrial cancer risk—challenging the long-held belief that obesity is the primary driver. The findings could lead to better screening of the women most at risk of developing the disease.
Using GLP-1s to maintain a normal weight? There are benefits and risksUsing GLP-1s to maintain a normal weight? There are benefits and risks
Drugs like Zepbound and Wegovy are intended for people who are overweight. Some patients are using them after bariatric surgery to keep pounds from creeping back. Others may just want to lose a few pounds. (Image credit: Christie Woodard) Drugs like Zepbound and Wegovy are intended for people who are overweight. Some patients are Read More
More Good News for GLP-1 Agonists and Cancer RiskMore Good News for GLP-1 Agonists and Cancer Risk
(MedPage Today) — Women with nonmalignant uterine disease and a history of GLP-1 agonist and progestin treatment had a significantly lower risk of endometrial cancer (EC) compared with progestins alone, a retrospective study showed. Based on… (MedPage Today) — Women with nonmalignant uterine disease and a history of GLP-1 agonist and progestin treatment had Read More
Does Abortion or Miscarriage Contribute to Breast Cancer Risk?Does Abortion or Miscarriage Contribute to Breast Cancer Risk?
(MedPage Today) — A history of induced abortion or miscarriage was not associated with an increased risk of breast cancer, according to a Finnish case-control study.
For women with a history of one or more induced abortions compared with women…
The Scan by 2 Minute Medicine®: Daily caffeine intake linked to lower dementia risk, AAP sues over federal vaccine schedule overhaul, Catherine O’Hara passes away after short illness, and GLP-1 receptor agonists reduce endometrial cancer riskThe Scan by 2 Minute Medicine®: Daily caffeine intake linked to lower dementia risk, AAP sues over federal vaccine schedule overhaul, Catherine O’Hara passes away after short illness, and GLP-1 receptor agonists reduce endometrial cancer risk
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. Moderate caffeine intake linked to significantly lower dementia risk Recent longitudinal data suggests that your morning coffee or tea might be doing more than just waking you up. A massive study involving over 400,000 participants Read More
Blockbuster weight loss drugs like Ozempic deliver big results but face big questionsBlockbuster weight loss drugs like Ozempic deliver big results but face big questions
Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide (Victoza and Saxenda) can lead to substantial weight loss in people with obesity. But while the results are impressive, researchers caution that most trials were funded by drugmakers, long Read More
DNA barcoding reveals the complexity of breast cancer liquid biopsiesDNA barcoding reveals the complexity of breast cancer liquid biopsies
Australian scientists have discovered that DNA barcoding can be used to track cancer cells in solid and liquid biopsies, empowering future research into more reliable breast cancer diagnosis and treatment strategies. The work is published in Molecular Systems Biology.